IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.518
NA - Nord America 3.555
AS - Asia 2.974
SA - Sud America 669
Continente sconosciuto - Info sul continente non disponibili 229
AF - Africa 32
Totale 12.977
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.085
US - Stati Uniti d'America 3.477
SG - Singapore 1.053
IE - Irlanda 607
CN - Cina 595
HK - Hong Kong 579
BR - Brasile 560
VN - Vietnam 391
GB - Regno Unito 250
KR - Corea 181
DE - Germania 156
IT - Italia 141
GR - Grecia 113
SE - Svezia 43
AR - Argentina 42
IN - India 40
UA - Ucraina 38
CA - Canada 32
FR - Francia 24
ID - Indonesia 23
MX - Messico 23
BD - Bangladesh 20
TR - Turchia 20
EC - Ecuador 19
CO - Colombia 17
JP - Giappone 16
FI - Finlandia 13
PY - Paraguay 12
ZA - Sudafrica 12
IQ - Iraq 10
NL - Olanda 10
PK - Pakistan 10
UZ - Uzbekistan 8
AT - Austria 7
VE - Venezuela 6
CL - Cile 5
CR - Costa Rica 5
MA - Marocco 5
BE - Belgio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
ES - Italia 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
JO - Giordania 2
LV - Lettonia 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BZ - Belize 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SV - El Salvador 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 12.748
Salva come PNG Salva come JPEG
Città #
Moscow 1.377
Dublin 607
Hong Kong 573
Chicago 538
Santa Clara 501
Wilmington 441
Singapore 435
Falls Church 338
San Jose 187
Jacksonville 178
Seoul 176
Ashburn 152
Council Bluffs 129
Ho Chi Minh City 123
Beijing 122
Princeton 110
Roxbury 108
Chandler 103
Bremen 102
Hanoi 100
Medford 75
Hefei 71
Des Moines 41
Cambridge 35
São Paulo 35
Dallas 26
Naples 26
Rome 26
Da Nang 24
Los Angeles 24
Bengaluru 19
The Dalles 19
Rio de Janeiro 18
New York 16
Nanjing 15
Frankfurt am Main 14
Guangzhou 14
Belo Horizonte 13
Ann Arbor 12
Jinan 12
Curitiba 11
Guarulhos 11
Hải Dương 11
Atlanta 10
Brasília 10
Caserta 10
Thái Bình 10
Boardman 9
Mexico City 9
Montreal 9
Ottawa 9
Shanghai 9
Tianjin 9
Amsterdam 8
Biên Hòa 8
Hangzhou 8
Hebei 8
Munich 8
Salvador 8
Shenyang 8
Tashkent 8
Baghdad 7
Haiphong 7
Johannesburg 7
Ningbo 7
Phoenix 7
Thái Nguyên 7
Bắc Ninh 6
Changsha 6
Guayaquil 6
Kunming 6
Phủ Lý 6
Santo André 6
Athens 5
Bagnoli Irpino 5
Bogotá 5
Campinas 5
Caxias do Sul 5
Ciudad del Este 5
Dearborn 5
Falkenstein 5
Helsinki 5
Houston 5
Lấp Vò 5
Marsico Nuovo 5
Natal 5
Nha Trang 5
Ninh Bình 5
Nuremberg 5
Ribeirão Preto 5
San José 5
Seattle 5
Woodbridge 5
Afragola 4
Aparecida de Goiânia 4
Asunción 4
Brussels 4
Campo Grande 4
Chennai 4
Contagem 4
Totale 7.332
Salva come PNG Salva come JPEG
Nome #
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 1.388
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 187
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 152
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 151
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 139
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 136
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 136
. FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells. 127
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 122
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). 122
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 120
Association of FASG670A gene polymorphism with systemic sclerosis. 120
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 119
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 119
Angiogenic cytokines and growth factors in systemic sclerosis 119
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 117
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome 117
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 117
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 117
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 115
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 111
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 110
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 107
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 106
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 104
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 103
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 103
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 102
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 99
Interstitial lung disease in systemic sclerosis: current and future treatment 98
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 98
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 97
Cardiovascular disease in primary sjögren’s syndrome 97
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 97
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 96
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 96
Interleukin-33 and its receptor st2 may serve as 'alarmin' system of the progressing damage to the skin and visceral organs of systemic sclerosis (ssc) patients 96
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 95
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 95
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 94
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 94
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 93
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients 92
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 92
AI-Based HRCT Quantification in Connective Tissue Disease-Associated Interstitial Lung Disease 91
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 91
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 91
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 91
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION 90
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 90
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease. 90
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 89
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 89
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 89
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy 89
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implication. 89
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) 89
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 87
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 87
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 87
The Vessels Contribute to Fibrosis in Systemic Sclerosis 87
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 87
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis 87
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine 87
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 86
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 86
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 86
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 86
Towards a consensus on the clinical applications and interpretations of the nailfold capillaroscopy standards in clinical practice: An initiative by the Egyptian Society of Microcirculation 85
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 84
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 83
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 83
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. 83
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 83
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 83
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage 83
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma 83
Macitentan inhibits the transforming growth factor-βprofibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts. 83
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 83
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients. 81
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 81
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series 81
SDF-1 expression in the skin of SSc patients. 80
Methotrexate: an old new drug in autoimmune disease 80
Cellular players in angiogenesis during the course of systemic sclerosis 79
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 79
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 78
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 78
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 78
Pigment epithelium derived factor secreted by ssc fibroblasts inhibits angio and vasculogenesis in vitro. 78
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 77
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 77
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 77
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 77
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 76
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosis. 76
Decreased expression of angiopoietin 1 on perivascular mesenchymalstemcells from SSc patients induces an anti angiogenic effect, when co-cultured with endothelial cells 76
Potential of stem cells in the treatment of rheumatic didease 76
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients 75
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 74
Totale 10.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.075
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.240 0 0 258 115 322 30 24 25 43 30 84 309
2022/20231.336 206 85 308 14 138 37 0 27 503 2 5 11
2023/2024356 18 9 3 7 160 10 6 12 4 7 9 111
2024/20251.826 1 0 3 31 240 283 292 165 231 395 111 74
2025/20266.939 258 343 425 482 652 3.766 270 254 224 128 105 32
2026/2027362 61 254 47 0 0 0 0 0 0 0 0 0
Totale 12.977